4 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow BCC: new trials by email Literature Review of BCC trials Research Report on BCC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults High Intensity Focused Ultrasound, Cryotherapy - Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma | Not applicable | Not yet recruiting | Jussi Salonen | 294 | 2026-04-01 | 2026-02-03 |
| The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes BCC - Basal Cell Carcinoma, BCC | Completed | Vejle Hospital | 210 | 2024-04-04 | 2026-05-26 | |
| The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma 5-Fluorouracil, SURGERY - Basal Cell Carcinoma, BCC | Phase 3 | Unknown | University of Aleppo | 40 | 2023-05-25 | 2024-01-02 |
| A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer MQ719, Pembrolizumab - Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 56 | 2023-05-04 | 2026-08-12 |
| CellFX Treat & Resect Low-Risk BCC Feasibility Study CellFX System - BCC - Basal Cell Carcinoma, BCC | Not applicable | Completed | Pulse Biosciences, Inc. | 30 | 2021-06-02 | 2023-01-11 |
| Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma Jet injection of ALA, Surgical excision, Illumination - BCC, BCC - Basal Cell Carcinoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 16 | 2020-09-09 | 2026-06-18 |
| Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study Oshadi D & Oshadi R - BCC | Phase 2 | Completed | Oshadi Drug Administration | 30 | 2013-11-01 | 2018-04-18 |
Carcinoma, Basal Cell (6) · Skin Neoplasms (2) · Adenocarcinoma, Sebaceous (1) · Bowen's Disease (1) · Carcinoma (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Skin Appendage (1) · Carcinoma, Squamous Cell (1) · Eyelid Diseases (1) · Eyelid Neoplasms (1) · Hemangiosarcoma (1) · Hypersensitivity (1) · Margins of Excision (1) · Melanoma (1) · Neoplasm Metastasis (1)
Neoplasms by Histologic Type (6) · Carcinoma (5) · Neoplasms (5) · Neoplasms, Basal Cell (5) · Neoplasms, Glandular and Epithelial (5) · Pathological Conditions, Signs and Symptoms (3) · Head and Neck Neoplasms (2) · Neoplasms by Site (2) · Neoplasms, Squamous Cell (2) · Pathologic Processes (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Squamous Cell (1) · DNA Virus Infections (1)
Cryotherapy (1) · Fluorouracil (1) · Infectious Disease Incubation Period (1) · Lighting (1) · Surgical Procedures, Operative (1) · pembrolizumab (1)
Memorial Sloan Kettering Cancer Center (2) · Jussi Salonen (1) · Oshadi Drug Administration (1) · Pulse Biosciences, Inc. (1) · University of Aleppo (1) · Vejle Hospital (1)
United States (3) · Denmark (1) · Finland (1) · Israel (1) · Syria (1)
Ahmad Yamen Arnaout, M.D. (1) · Anthony Rossi, MD (1) · Lara Dunn, MD (1) · Lior Heller, Prof. (1) · Noura Abdulrahman, M.D. (1) · Richard A. Nuccitelli, PhD (1) · Sari Koskenmies, Head of Department (1) · Silva Ishkhanian, PhD (1)